Annual FCF
-$55.84 M
-$12.21 M-27.99%
31 December 2023
Summary:
ArriVent BioPharma Common Stock annual free cash flow is currently -$55.84 million, with the most recent change of -$12.21 million (-27.99%) on 31 December 2023. AVBP annual FCF is now -27.99% below its all-time high of -$43.63 million, reached on 31 December 2022.AVBP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$16.34 M
+$2.74 M+14.37%
01 September 2024
Summary:
ArriVent BioPharma Common Stock quarterly free cash flow is currently -$16.34 million, with the most recent change of +$2.74 million (+14.37%) on 01 September 2024. Over the past year, it has dropped by -$1.43 million (-9.60%). AVBP quarterly FCF is now -89.93% below its all-time high of -$8.61 million, reached on 01 June 2023.AVBP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$68.97 M
-$903.00 K-1.33%
01 September 2024
Summary:
ArriVent BioPharma Common Stock TTM free cash flow is currently -$68.97 million, with the most recent change of -$903.00 thousand (-1.33%) on 01 September 2024. Over the past year, it has dropped by -$13.13 million (-23.51%). AVBP TTM FCF is now -148.61% below its all-time high of -$27.74 million, reached on 01 September 2022.AVBP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVBP Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -9.6% | -23.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
AVBP Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
| 5 y | 5 years | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
| alltime | all time | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
ArriVent BioPharma Common Stock Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.34 M(-14.4%) | -$68.97 M(+1.3%) |
| June 2024 | - | -$19.09 M(+2.5%) | -$68.07 M(+18.2%) |
| Mar 2024 | - | -$18.63 M(+24.9%) | -$57.59 M(+3.1%) |
| Dec 2023 | -$55.84 M | -$14.91 M(-3.4%) | -$55.84 M(+36.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$15.44 M(+79.4%) | -$40.93 M(-23.1%) |
| June 2023 | - | -$8.61 M(-49.0%) | -$53.23 M(+19.3%) |
| Mar 2023 | - | -$16.88 M(-39.2%) | -$44.63 M(+60.8%) |
| Dec 2022 | -$43.63 M | - | - |
| Sept 2022 | - | -$27.74 M | -$27.74 M |
FAQ
- What is ArriVent BioPharma Common Stock annual free cash flow?
- What is the all time high annual FCF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock quarterly free cash flow?
- What is the all time high quarterly FCF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock quarterly FCF year-on-year change?
- What is ArriVent BioPharma Common Stock TTM free cash flow?
- What is the all time high TTM FCF for ArriVent BioPharma Common Stock?
- What is ArriVent BioPharma Common Stock TTM FCF year-on-year change?
What is ArriVent BioPharma Common Stock annual free cash flow?
The current annual FCF of AVBP is -$55.84 M
What is the all time high annual FCF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high annual free cash flow is -$43.63 M
What is ArriVent BioPharma Common Stock quarterly free cash flow?
The current quarterly FCF of AVBP is -$16.34 M
What is the all time high quarterly FCF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high quarterly free cash flow is -$8.61 M
What is ArriVent BioPharma Common Stock quarterly FCF year-on-year change?
Over the past year, AVBP quarterly free cash flow has changed by -$1.43 M (-9.60%)
What is ArriVent BioPharma Common Stock TTM free cash flow?
The current TTM FCF of AVBP is -$68.97 M
What is the all time high TTM FCF for ArriVent BioPharma Common Stock?
ArriVent BioPharma Common Stock all-time high TTM free cash flow is -$27.74 M
What is ArriVent BioPharma Common Stock TTM FCF year-on-year change?
Over the past year, AVBP TTM free cash flow has changed by -$13.13 M (-23.51%)